INVESTMENT AGREEMENTInvestment Agreement • February 13th, 2024 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • New York
This INVESTMENT AGREEMENT (this “Agreement”) is made and entered into as of February 13, 2024, by and among CRISPR Therapeutics AG, a stock corporation (Aktiengesellschaft) incorporated under the laws of Switzerland (the “Company”), and the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively the “Investors”).
